Nationwide Children's Events & Announcements
Viewing: 111-120 of 974 | All
Mar 15, 2022
Catherine Krawczeski, MD, Named Chief of the Department of Pediatrics at Nationwide Children’s Hospital
Catherine Dent Krawczeski, MD, has been named Physician-in-Chief and Chief of the Department of Pediatrics at Nationwide Children’s Hospital. Dr. Krawczeski will also serve as Chair of Pediatrics at The Ohio State University College of Medicine, pending approval from The Ohio State University Board of Trustees. Dr. Krawczeski will begin this new role in Summer 2022.
Mar 09, 2022
Early Phase Gene Therapy Study for SMARD1/CMT2S Disease Now Enrolling
Nationwide Children's Hospital has launched a new Phase I/IIa gene replacement clinical study to evaluate the safety of a gene therapy for IGHMBP2-related diseases, specifically spinal muscular atrophy with respiratory distress type 1 (SMARD1) and Charcot Marie Tooth disease type 2S (CMT2S). SMARD1 and CMT2S are rare inherited conditions that are both caused by mutations in the IGHMBP2 gene, of which more than 60 have been found to date. SMARD1 is the most severe form of these diseases and causes muscle weakness and respiratory failure in infancy.
Feb 25, 2022
Dennis Durbin, MD, MSCE, Named President of the Abigail Wexner Research Institute at Nationwide Children’s Hospital
Beginning March 1, 2022, Dennis Durbin, MD, MSCE, will become the third president of the Abigail Wexner Research Institute at Nationwide Children's Hospital. Dr. Durbin joined Nationwide Children's in 2018 as its first chief scientific officer.
Feb 03, 2022
New Study Finds High-Powered Magnets Lead to Hospitalizations and Life-Threatening Injuries in Children
A recent study led by researchers at the Center for Injury Research and Policy and Emergency Medicine at Nationwide Children’s Hospital along with 24 other children’s hospitals across the country looked at nearly 600 cases of high-powered magnet-related injuries in the three years after high-powered magnets re-entered the US market (2017 to 2019).
Feb 01, 2022
Study supports virotherapy as a potential treatment for brain tumors
A new study provides additional evidence of the efficacy of virotherapy for glioblastoma, the most deadly type of brain tumor. The research findings, published Feb. 1, 2022, in Clinical Cancer Research, indicate that an oncolytic herpes simplex virus, G207, appears to boost immune response and that this is associated with better overall survival for patients with glioblastoma.
Jan 26, 2022
Nationwide Children’s Hospital Researcher Lauren Bakaletz, PhD, Honored by AAAS as Lifetime AAAS Fellow
The American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science family of journals, has elected Lauren Bakaletz, PhD, director of the Center for Microbial Pathogenesis in the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital to the newest class of AAAS Fellows, among the most distinct honors within the scientific community.
Dec 16, 2021
Nationwide Children’s Hospital Receives $50,000 Donation from Mom of Two Young Adults, to Help Support Signs of Suicide® and Big Lots Behavioral Health Services Mood and Anxiety Program
Nationwide Children’s Hospital today announced a $50,000 gift from Maureen Considine Gharrity, Founding Director of Quinn’s Memorial Foundation and Erinn’s Grace Foundation both created to honor her two children, as a gift as well as philanthropic efforts.
Dec 08, 2021
Variety of Opportunities Available to Provide Holiday Delight to Patients at Nationwide Children’s Hospital
During this holiday season, the local community, and supporters of Nationwide Children’s Hospital around the country are welcome to bring seasonal cheer to patients at the hospital.
Dec 03, 2021
2021 Nationwide Children’s Hospital Championship announces record-setting $3,186,546 charitable donation
Tournament officials announced today that the 15th playing of the Nationwide Children’s Hospital Championship, concluded August 29, 2021, at The Ohio State University Golf Club - Scarlet Course, raised a total of $3,186,456 for central Ohio charitable organizations, including $3,006,376 for pediatric cancer research and treatment at Nationwide Children’s Hospital.
Dec 02, 2021
The Memorial Tournament Presented by Workday Announces 2021 Charitable Donation
Officials of the Memorial Tournament presented by Workday announced today that the 46th playing of the prestigious invitational, concluded June 6, 2021, raised $2,550,000 for Nationwide Children’s Hospital through an alliance with the Nicklaus Children’s Health Care Foundation.